Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jefferies Maintains Buy on PAR Technology, Lowers Price Target to $43

Jefferies analyst Samad Samana maintains PAR Technology (NYSE:PAR) with a Buy and lowers the price target from $55 to $43.

byBenzinga Newsdesk

May 23, 2022

1 minute read

Jefferies analyst Samad Samana maintains PAR Technology (NYSE:PAR) with a Buy and lowers the price target from $55 to $43.

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

By Benzinga Insights

Today, 11:05 PM

Danaher (NYSE:DHR) has outperformed the market over the past 5 years by 13.99% on an annualized basis producing…

DHR

Baird Maintains Underperform on Bed Bath & Beyond, Lowers Price Target to $1

By Benzinga Newsdesk

Today, 11:05 PM

Baird analyst Justin Kleber maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Underperform and lowers the price target from $2 to $1.

BBBY

Why Apellis Pharmaceutical Shares Are Plunging Today

By Adam Eckert

Today, 11:05 PM

Apellis Pharmaceuticals Inc (NASDAQ: APLS) is trading lower Friday after the company announced its Phase 3 DERBY study in geographic atrophy did not meet the primary endpoint of GA lesion growth.

APLS

Delivra Health Brands Sells Its Lucky Lake Facility For $3M

By Vuk Zdinjak

Today, 11:05 PM

Delivra Health Brands Inc. (OTCQB: DHBUF) (TSXV: DHB) , a consumer packaged goods company working in the health and wellness sector, announced that its wholly-owned subsidiary, United Greeneries Holdings Ltd., has sold and transferred the title of its Lucky Lake Fac

DHBUF

Jefferies Maintains Buy on PAR Technology, Lowers Price Target to $43

Related Posts

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

Baird Maintains Underperform on Bed Bath & Beyond, Lowers Price Target to $1

Why Apellis Pharmaceutical Shares Are Plunging Today

Delivra Health Brands Sells Its Lucky Lake Facility For $3M